Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immunotech Biopharm Ltd ( (HK:6978) ) has issued an announcement.
Immunotech Biopharm Ltd has requested a halt in trading of its shares on the Hong Kong Stock Exchange, effective from 1:00 p.m. on 28 April 2026. The suspension is pending the release of an announcement containing inside information, signaling that a potentially material corporate development is imminent for shareholders and the market.
The company has not yet disclosed the nature of the inside information, leaving investors without details on whether it relates to operational, financial, strategic or regulatory matters. Market participants are likely to closely watch the forthcoming announcement, as trading halts tied to inside information can precede significant shifts in valuation or corporate direction.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a biopharmaceutical company listed on the Hong Kong Stock Exchange, focusing on the development and commercialization of innovative therapies. The company operates through a board comprising executive, non-executive and independent non-executive directors, reflecting a typical Hong Kong–listed corporate governance structure.
Average Trading Volume: 377,594
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.82B
Learn more about 6978 stock on TipRanks’ Stock Analysis page.